Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

20. April 2018 07:00 ET | Quelle: Valeritas, Inc.

Valeritas Teams with Glooko as its Preferred Data Management Partner for V-Go® SIM™

BRIDGEWATER, N.J., April 20, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company which offers patients with type 2 diabetes V-Go® Wearable Insulin Delivery...
17. April 2018 07:00 ET | Quelle: Valeritas, Inc.

Valeritas Announces V-Go® Distribution Agreement in Australia and New Zealand

BRIDGEWATER, N.J., April 17, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company which offers patients with type 2 diabetes V-Go® Wearable Insulin Delivery...
02. März 2018 07:00 ET | Quelle: Valeritas, Inc.

Valeritas to Present at Upcoming Investor Conferences

BRIDGEWATER, N.J., March 02, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company which offers patients with type 2 diabetes V-Go® Wearable Insulin Delivery...
26. Februar 2018 16:03 ET | Quelle: Valeritas, Inc.

Valeritas Reports Fourth Quarter and Full Year 2017 Financial Results

BRIDGEWATER, N.J., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company which offers patients with type 2 diabetes V-Go® Wearable Insulin Delivery...
22. Februar 2018 07:00 ET | Quelle: Valeritas, Inc.

Valeritas Announces V-Go® Distribution Agreement in Italy with Movi SpA

BRIDGEWATER, N.J., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company which offers patients with type 2 diabetes V-Go® Wearable Insulin Delivery...
15. Februar 2018 08:00 ET | Quelle: Valeritas, Inc.

Valeritas Presents Data Demonstrating V-Go® Wearable Insulin Delivery Device Significantly Reduces A1C and Insulin Requirements in Patients with Type 2 Diabetes, When Combined with a Simplified Insulin Titration Algorithm

BRIDGEWATER, N.J., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company which offers patients with type 2 diabetes V-Go® Wearable Insulin Delivery...
12. Februar 2018 08:00 ET | Quelle: Valeritas, Inc.

Valeritas to Report Fourth Quarter 2017 Results February 26, 2018

BRIDGEWATER, N.J., Feb. 12, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company which offers patients with type 2 diabetes V-Go® Wearable Insulin Delivery...
09. Februar 2018 08:00 ET | Quelle: Valeritas, Inc.

Valeritas to Host Investor Meetings at the 2018 BTIG Medical Technology, Life Science, and Diagnostic Tools Conference

BRIDGEWATER, N.J., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company which offers patients with type 2 diabetes V-Go® Wearable Insulin Delivery...
17. Januar 2018 08:00 ET | Quelle: Valeritas, Inc.

Valeritas Announces its V-Go® Wearable Insulin Delivery Device is now available in Puerto Rico

BRIDGEWATER, N.J., Jan. 17, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company which offers patients with type 2 diabetes V-Go® Wearable Insulin Delivery...
09. Januar 2018 07:30 ET | Quelle: Valeritas, Inc.

Valeritas Appoints Joseph Saldanha as Chief Business Officer

BRIDGEWATER, N.J., Jan. 09, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company which offers patients with type 2 diabetes V-Go® Wearable Insulin Delivery...

Vorherige Seite

Nächste Seite